Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

211

HTML

1998

Figures (1-1)

252

Tables (1-4)

223

Sum=2684

Jul 7, 2005 (publication date) through Dec 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Jul 7, 2005; 11(25): 3823-3829
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3823

Table 4 Median survivals and survival rates with subgroups divided by prognosis index (%)

Citation: Zhu SC, Li R, Wang YX, Feng W, Li J, Qiu R. Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system. World J Gastroenterol 2005; 11(25): 3823-3829
URL: https://www.wjgnet.com/1007-9327/full/v11/i25/3823.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i25.3823